These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38443298)

  • 21. Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline.
    Johansson M; Stomrud E; Johansson PM; Svenningsson A; Palmqvist S; Janelidze S; van Westen D; Mattsson-Carlgren N; Hansson O
    Biol Psychiatry; 2022 Jul; 92(1):34-43. PubMed ID: 35346458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity.
    Costoya-Sánchez A; Moscoso A; Silva-Rodríguez J; Pontecorvo MJ; Devous MD; Aguiar P; Schöll M; Grothe MJ;
    JAMA Neurol; 2023 Oct; 80(10):1051-1061. PubMed ID: 37578787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
    Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
    Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
    Leuzy A; Binette AP; Vogel JW; Klein G; Borroni E; Tonietto M; Strandberg O; Mattsson-Carlgren N; Palmqvist S; Pontecorvo MJ; Iaccarino L; Stomrud E; Ossenkoppele R; Smith R; Hansson O;
    JAMA Neurol; 2023 Jun; 80(6):614-623. PubMed ID: 37155176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers.
    Gordon BA; Blazey TM; Christensen J; Dincer A; Flores S; Keefe S; Chen C; Su Y; McDade EM; Wang G; Li Y; Hassenstab J; Aschenbrenner A; Hornbeck R; Jack CR; Ances BM; Berman SB; Brosch JR; Galasko D; Gauthier S; Lah JJ; Masellis M; van Dyck CH; Mintun MA; Klein G; Ristic S; Cairns NJ; Marcus DS; Xiong C; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Brain; 2019 Apr; 142(4):1063-1076. PubMed ID: 30753379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's pathology targets distinct memory networks in the ageing brain.
    Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
    Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
    Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
    Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.
    Gonzalez C; Mimmack KJ; Amariglio RE; Becker JA; Chhatwal JP; Fitzpatrick CD; Gatchel JR; Johnson KA; Katz ZS; Kuppe MK; Locascio JJ; Udeogu OJ; Papp KV; Premnath P; Properzi MJ; Rentz DM; Schultz AP; Sperling RA; Vannini P; Wang S; Marshall GA
    J Alzheimers Dis; 2023; 94(1):217-226. PubMed ID: 37212093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.
    Ozlen H; Pichet Binette A; Köbe T; Meyer PF; Gonneaud J; St-Onge F; Provost K; Soucy JP; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
    JAMA Neurol; 2022 Oct; 79(10):1025-1035. PubMed ID: 35994280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Yang HS; Yau WW; Carlyle BC; Trombetta BA; Zhang C; Shirzadi Z; Schultz AP; Pruzin JJ; Fitzpatrick CD; Kirn DR; Rabin JS; Buckley RF; Hohman TJ; Rentz DM; Tanzi RE; Johnson KA; Sperling RA; Arnold SE; Chhatwal JP
    Brain; 2024 Jun; 147(6):2158-2168. PubMed ID: 38315899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthreshold Amyloid Predicts Tau Deposition in Aging.
    Leal SL; Lockhart SN; Maass A; Bell RK; Jagust WJ
    J Neurosci; 2018 May; 38(19):4482-4489. PubMed ID: 29686045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone therapy is associated with lower Alzheimer's disease tau biomarkers in post-menopausal females -evidence from two independent cohorts.
    Wang YT; Therriault J; Tissot C; Servaes S; Rahmouni N; Macedo AC; Fernandez-Arias J; Mathotaarachchi SS; Stevenson J; Lussier FZ; Benedet AL; Pascoal TA; Ashton NJ; Zetterberg H; Blennow K; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2024 Jul; 16(1):162. PubMed ID: 39034389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.
    Sperling RA; Mormino EC; Schultz AP; Betensky RA; Papp KV; Amariglio RE; Hanseeuw BJ; Buckley R; Chhatwal J; Hedden T; Marshall GA; Quiroz YT; Donovan NJ; Jackson J; Gatchel JR; Rabin JS; Jacobs H; Yang HS; Properzi M; Kirn DR; Rentz DM; Johnson KA
    Ann Neurol; 2019 Feb; 85(2):181-193. PubMed ID: 30549303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
    Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
    JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
    Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
    Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated plasma neurofilament light was associated with multi-modal neuroimaging features in Alzheimer's disease signature regions and predicted future tau deposition.
    Hu Q; Shi M; Li Y; Zhao X
    BMC Neurol; 2024 Jul; 24(1):236. PubMed ID: 38971733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    McGrath ER; Beiser AS; O'Donnell A; Yang Q; Ghosh S; Gonzales MM; Himali JJ; Satizabal CL; Johnson KA; Tracy RP; Seshadri S
    J Alzheimers Dis; 2022; 87(4):1517-1526. PubMed ID: 35491781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.